Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central sensitization intervention study in knee arthroplasty candidates
ChiCTR2000031674Phase 4Not yet recruiting
- Sponsor
- Ningbo No. 6 Hospital
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 4 trial of Placebo-COD Research Private Ltd in Central sensitization (CS) and osteoarthritis (OA) (3 arms), sponsored by Ningbo No. 6 Hospital. Primary endpoints: Knee Osteoarthritis Outcome Score, Visual Analogue Scale and 1 more. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
Central sensitization (CS)osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2000031674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031674.